Home » Topics » Regulatory » Patents

Patents
RSS

Recent patents disclose new therapeutic agents for anxiety, depression, etc.

Dec. 13, 2006

Recent patents report novel analgesic agents

Dec. 13, 2006

New agents for urinary incontinence emerge from Astellas Pharma R&D

Dec. 13, 2006

Novel agents for treating neurological disorders disclosed in recent Neuren and Santhera patents

Dec. 12, 2006

Recent patents report new therapeutic agents for endocrine-related disorders

Dec. 12, 2006

Recent patents reveal novel antiarthritic agents

Dec. 12, 2006

Novel antibacterial drugs disclosed in recent patents

Dec. 11, 2006

Recent Novartis and Almirall patents describe new therapeutic agents for respiratory disorders

Dec. 11, 2006

Recent patents describe new agents with potential as cardiovascular disorder treatments

Dec. 11, 2006

Novel agents for thrombotic disorders disclosed in recent patents

Dec. 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...